Beginner's Mind

Do you want to reach out to Japanese companies and universities? Then you should know what makes Japan special and different to have a smooth business experience. Different Cultures – Different Rules and Different ways to success Japan is the second biggest market for pharmaceuticals globally. The area is not only interesting for its sales potential; it is also a major R&D hub in Asia. One of...

Did you know that almost 90% of all product ideas fail in clinical trials?  Surprising to me was that lack of efficacy doesn't seem to be the main reason why clinical trials fail in the first place. Other factors are at play, and most of them are manageable risks when the right team is at work. In this episode: Strategic considerations for setting up a clinical trial Inhouse vs Outsourced Cli...

Big corporations strive to bring new solutions to their customers to help them solve their most pressing problems. To do so the corporation needs to be innovative. That's why companies like Apple, Google, Pfizer, and similar players want to cooperate with start-ups and scale-ups globally. Such cooperations strive to collaborate with top startups, invest in them, and sometimes acquire them to...

Lately, investors and researchers have published more and more information on longevity research and development. Investors like Sergey Young or  Christian Angermayer started to bet significant capital on this topic. What is going on in this field on the research side? What are potential applications to increase the Lifespan? And when will those innovations hit the market? In this episode, I had a...

What significant problems does the food industry face today? Which solutions are already in development? In this episode, I am talking with Mauricio Agudelo and Lina María Toro about Sustainable Food Innovation in South America. BIALTEC assists animal protein producers to improve productivity and profitability through precision nutrition, understanding their particular dietary needs, analyzing the...

Innovation needs collaboration on a global scale. Making things happen requires entrepreneurs who love science and work day and night to connect the best minds globally and support them to translate their science into products and businesses. In this episode, I have a conversation with Kai Lamottke, CEO and Co-Founder of Bicoll . Dr. Kai Lamottke is co-founder & CEO of Bicoll GmbH and Bicoll B...

Part 7 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Formula 1 Fuels Hand Sanitization Open Source and Technology I hope you enjoy the conversation the same way I did. Who are the Experts in thi...

Part 6 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about NFTs Metaverse NanoMetaGames Austrian Entrepreneurship Week From Morning Moonshots to Future Weekly Apple & Spotify Podcast Algorithms I...

Part 5 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about The Effects of the Pandemic on Business Life The Future of ADCs in Oncology Mental Health Psychedelic Drug Development Gilgamesh Pharmaceutic...

Part 4 of the Year in Review Recording. 1 hour minutes of inspiring conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Biotech in Austria Culture of Success Business Angels, Investment and Market Perspective Customer Needs and Entrepreneurship I hope you enjoy...

Part 3 of the Year in Review Recording. 1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Content Marketing with a Podcast Life Science Industry in Austria Content Marketing and Social Media for B2B Businesses History of the Vien...

Part 2 of the Year in Review Recording.  1 hour 15 minutes of exciting conversations with speakers from previous podcast episodes and business partners of the hosts.  What was hot in 2021, and what do our speakers expect for 2022? In this episode, we talk about Health Literacy and the Healthcare System Venture Capital in 2021 Digitalization in Drug Development The Golden Age of Biotech Home Office...

This is Part 1 of the 7,5 hours conversations marathon before Christmas with speakers from previous podcast episodes and business partners of the host and co-host of the Podcast. In this episode, we talk about Covid19  Cryptocurrencies Cybersecurity and Merger & Acquisition I hope you enjoy the conversation the same way as I did. Who are the Experts in this episode: Astrid Woollard Dusica Luka...

In this episode, I am having a conversation with Sascha Berger , Partner at TVM Capital . Dr. Sascha Berger is a Partner at TVM Capital, based in Munich, Germany. TVM Capital is one of the pioneer transatlantic Life Science Venture Capital funds with Europe and North America teams. Sascha joined TVM Capital in 2016, helped raise the current $480M fund, and works closely with entrepreneurs and foun...

In this episode, I am having a conversation with Bettina Resl, Public Affairs Head Europe Consumer Healthcare at Sanofi. Bettina Resl joined Sanofi Austria in May 2017 as Country Head Public Affairs & Patient Advocacy. From April 2020 to June 2021 she was also responsible for corporate communications and finally took over the position of Public Affairs Head Europe Consumer Healthcare at Sanofi...

In this episode, I have a conversation with Jaromir Zahradka and we will talk about early-stage investments in DeepTech Life Science companies.  He has 5+ years of C-level experience and has been engaged in 8 Biotech spin-offs.  He built a unique network within CE institutions and TTOs and has deep scientific and licensing market expertise with over 20 licensing deals worth more than USD 500m.  Ja...

In today’s episode, we explore Clinical Development with Ole Dammann, the owner of KFGN, a group of 6 clinical trial sites in Germany, and after joining Pratia, several sites in Eastern Europe. Ole Dammann is one of the best experts in clinical trial management in the LSG2G Community. Ole is currently working on the digitization of clinical research and the development of new business models. In t...

In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe. Topics we discuss in the show: The Development of the Life Science Eco-System in Europe How Family Offices Support Life Science Companies in Europe How to Translate Science into Business Does Europe Have a Culture...

In this conversation, I will talk with Oliver Mavher and Michael Deichsel about Crypto Trading and taxes. Topics we discuss in the show: The questions that I consider relevant for everybody owning digital assets: What if someone gets paid in Bitcoin or other Cryptocurrencies? Is that a taxable event? What if someone invests in those novel digital assets and they gain in value? Does the location of...

In this conversation, we will talk about the future of the Early-Stage Ecosystem in Europe. Speaker in the Episode: Alexander Schwartz joined IST cube in 2018 as a Partner. He has more than 15 years of experience in management consulting, eight of which with McKinsey & Company. Ingrid Kelly Spillman joined the IST Tech Transfer team in October 2018. Ingrid worked as a patent attorney in and fo...

The industry gains complexity, and I am happy that a speaker from the LSG2G community has dedicated time to speak about the Future of the Food Industry. Speaker in the Episode: Dr. Caroline E. Heil Since Jul. 1, 2021, Caroline has been CEO of The New Meat Company AG, a young stock-listed, purpose-driven impact investment company in Berlin focusing on alternative proteins.  Caroline is intrigued by...

Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D. To gain more insights into this area, I invited a tech transfer expert from the LSG2G Community to this conversation. Speaker in this Episode is Saara Inkinen, Nordic Catalyst. Dr. Inkinen is a technology transfer and innovation management specialist ba...

In this conversation, we discuss the development of the European Pharma Eco-System, different business models, and what it takes to lead a company to success. Today’s speaker is Dimitrios Tzalis. In the 90s, he received a Ph. D. from the University of California, San Diego, a Master of Science in Chemistry from the University of Chicago, and a Master of Science in Biochemistry from Ball State Univ...

Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies. Timestamps: For those who want to listen to specific parts of the episode, here are the timestamps: 00:00 Opening Christian Soschner 02:00 Intro Andrea Sommer – Importance of Patents 03:48 The Role of Patents in Deep Tech Companies – Understanding the Importance of Patent Processes 13:51 Wha...

Here is my conversation with Kurt Höller and Joy Cürten from EIT Health about the health tech revolution in Europe and the Rest of the World. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/eit-health-and-the-international-514 Youtube:  https://youtu.be/OnQrvbgcO8Y Kurt Höller: https://www.linkedin.com/in/hoeller/ Joy Cürten: https://www.linkedin.com/in/joy-c%C3%BCrten-a8977241...